K-numberK250930
Device nametwiist system
ApplicantDeka Research & Development Corp.
Product codeQFG
Device classClass II
Decision dateApr 2, 2025
DecisionSubstantially Equivalent
Regulation880.5730
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The twiist system is a wearable insulin infusion pump for subcutaneous delivery of insulin at set and variable rates to manage diabetes in persons ages 6 and above. The pump communicates wirelessly with compatible digitally-connected devices, including automated insulin dosing software, to receive and execute commands. It includes a bolus calculator to aid users in determining insulin dosage based on carbohydrates, blood glucose, and other parameters.

Technological characteristics

The device uses the same microprocessor-controlled micro-dosing pump mechanism with acoustic volume sensing (AVS) feedback as the predicate. It delivers 0–30 units/hour basal rates and 0.05–25.00 unit boluses in 0.01 unit increments, with identical basal and bolus accuracy, occlusion detection timing, battery life (72 hours), compatible insulins (Humalog and Novolog U-100), and environmental specifications. The primary modification is the addition of three ConvaTec infusion set models to the compatible infusion set list.

Test standards cited

The device complies with IEC 60601-1, IEC 60601-1-2, IEC 60601-1-6, IEC 60601-1-8, IEC 60601-1-10, IEC 60601-1-11, IEC 60601-2-24, ISO 11137-1 (gamma sterilization), ISO 14971, and ISO 13485:2016. Biocompatibility is established per ISO 10993.

Substantial equivalence argument

The twiist system is substantially equivalent to the predicate DEKA ACE Pump System (K233952) because no changes to hardware or software were necessary; only labeling was modified to add three ConvaTec infusion sets. Bench performance testing using the same established test methodology and acceptance criteria from the predicate clearance demonstrated that the new ConvaTec infusion sets perform equivalently to the previously-cleared infusion sets. Since the ConvaTec sets have similar physical characteristics to existing compatible sets and the device's core performance parameters remain unchanged, no new safety or effectiveness questions are raised.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →